Syngene International’s Performance Analyzed

Syngene International, a company that helps other businesses make medicines and health products, recently reported some changes in how much money they were making and selling. Their sales dropped by 2.82% during the most recent three-month period, falling to Rs 917.10 crore. This is a decrease from the Rs 943.70 crore they sold during the previous three months.

Key Points

• Sales fell 2.82% to Rs 917.10 crore.
• Net profit plummeted 89% to Rs 15.00 crore.
• Operating profit margin decreased to 22.81%.
• Profit before tax (PBDT) dropped 27%.
• Profit after tax (PBT) fell 45%.
• Net profit decreased significantly to Rs 15 crore.

Financial Results Breakdown

Let’s look at the numbers more closely. The company’s profit, called net profit, took a big hit, falling down by 88.56% to just Rs 15.00 crore. This is a very big change compared to the previous quarter when they made Rs 131.10 crore. The percentage change shows a large decrease in their profitability.

Their operating profit margin, which shows how much money they make for every rupee they sell, also went down to 22.81% from 30.05%. This means they weren’t making as much money from each sale as they were before.

Before calculating the final profit, we look at Profit Before Tax (PBDT), which was Rs 212.70 crore, a drop of 27% from Rs 289.50 crore. This indicates a reduction in their earnings before accounting for taxes.

Finally, the Profit After Tax (PBT) decreased by 45% to Rs 99.00 crore compared to Rs 180.80 crore. This reflects a substantial reduction in their earnings after all taxes have been paid.

Important Note

These numbers show that Syngene International is facing some challenges. It’s important to understand why sales are down and how they can improve their profits.

The company’s recent financial performance highlights the need for strategic adjustments to maintain growth.